BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu X, Cheng W, Fan S, Huang Y, Chen X, Jiang Z, Wang J. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis. BMC Infect Dis 2021;21:583. [PMID: 34134659 DOI: 10.1186/s12879-021-06270-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Yano K, Sugita K, Muto M, Matsukubo M, Onishi S, Kedoin C, Matsui M, Murakami M, Harumatsu T, Yamada K, Yamada W, Kumagai K, Ido A, Kaji T, Ieiri S. The preventive effect of recombinant human hepatocyte growth factor for hepatic steatosis in a rat model of short bowel syndrome. Journal of Pediatric Surgery 2022. [DOI: 10.1016/j.jpedsurg.2022.02.030] [Reference Citation Analysis]
2 Tang Y, Feng M, Zhu X, Long J, Zhou Z, Liu S. WR-GLP2, a glucagon-like peptide 2 from hybrid crucian carp that protects intestinal mucosal barrier and inhibits bacterial infection. Fish & Shellfish Immunology 2022. [DOI: 10.1016/j.fsi.2022.01.035] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Xi L, Qin X, Song Y, Han J, Li Z, Zhang J. Gut Microbial Alterations in Diarrheal Baer's Pochards (Aythya baeri). Front Vet Sci 2021;8:756486. [PMID: 34722711 DOI: 10.3389/fvets.2021.756486] [Reference Citation Analysis]